nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—ALB—multiple sclerosis	0.269	1	CbGaD
Salicylic acid—SLC16A1—Methotrexate—multiple sclerosis	0.097	0.163	CbGbCtD
Salicylic acid—PTGS2—Triamcinolone—multiple sclerosis	0.0683	0.114	CbGbCtD
Salicylic acid—PTGS2—Betamethasone—multiple sclerosis	0.0586	0.0982	CbGbCtD
Salicylic acid—SLC22A11—Methotrexate—multiple sclerosis	0.0501	0.0839	CbGbCtD
Salicylic acid—SLC22A7—Methotrexate—multiple sclerosis	0.0477	0.0799	CbGbCtD
Salicylic acid—ALB—Prednisone—multiple sclerosis	0.0344	0.0577	CbGbCtD
Salicylic acid—PTGS2—Dexamethasone—multiple sclerosis	0.0341	0.0571	CbGbCtD
Salicylic acid—ABCB1—Methylprednisolone—multiple sclerosis	0.0297	0.0498	CbGbCtD
Salicylic acid—SLC22A8—Methotrexate—multiple sclerosis	0.0291	0.0488	CbGbCtD
Salicylic acid—ABCB1—Mitoxantrone—multiple sclerosis	0.0217	0.0364	CbGbCtD
Salicylic acid—SLC22A6—Methotrexate—multiple sclerosis	0.0203	0.034	CbGbCtD
Salicylic acid—ABCB1—Betamethasone—multiple sclerosis	0.0193	0.0324	CbGbCtD
Salicylic acid—ABCB1—Prednisolone—multiple sclerosis	0.0191	0.032	CbGbCtD
Salicylic acid—ABCB1—Prednisone—multiple sclerosis	0.018	0.0302	CbGbCtD
Salicylic acid—ALB—Methotrexate—multiple sclerosis	0.0173	0.029	CbGbCtD
Salicylic acid—CYP2C9—Dexamethasone—multiple sclerosis	0.0116	0.0194	CbGbCtD
Salicylic acid—ABCB1—Dexamethasone—multiple sclerosis	0.0112	0.0188	CbGbCtD
Salicylic acid—ABCB1—Methotrexate—multiple sclerosis	0.00904	0.0151	CbGbCtD
Salicylic acid—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00274	0.0372	CcSEcCtD
Salicylic acid—Epigastric pain—Mitoxantrone—multiple sclerosis	0.00202	0.0275	CcSEcCtD
Salicylic acid—Ecchymosis—Cladribine—multiple sclerosis	0.00134	0.0183	CcSEcCtD
Salicylic acid—Lethargy—Cladribine—multiple sclerosis	0.0011	0.015	CcSEcCtD
Salicylic acid—Stinging—Prednisolone—multiple sclerosis	0.000989	0.0135	CcSEcCtD
Salicylic acid—Stinging—Triamcinolone—multiple sclerosis	0.000909	0.0124	CcSEcCtD
Salicylic acid—Abdominal discomfort—Cladribine—multiple sclerosis	0.000894	0.0122	CcSEcCtD
Salicylic acid—Ecchymosis—Mitoxantrone—multiple sclerosis	0.000883	0.012	CcSEcCtD
Salicylic acid—Stinging—Betamethasone—multiple sclerosis	0.000825	0.0112	CcSEcCtD
Salicylic acid—Stinging—Dexamethasone—multiple sclerosis	0.000825	0.0112	CcSEcCtD
Salicylic acid—Epistaxis—Cladribine—multiple sclerosis	0.000784	0.0107	CcSEcCtD
Salicylic acid—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000727	0.00989	CcSEcCtD
Salicylic acid—Ecchymosis—Prednisolone—multiple sclerosis	0.000724	0.00986	CcSEcCtD
Salicylic acid—Erythema multiforme—Cladribine—multiple sclerosis	0.000705	0.0096	CcSEcCtD
Salicylic acid—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000703	0.00957	CcSEcCtD
Salicylic acid—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000702	0.00955	CcSEcCtD
Salicylic acid—Burning sensation—Methotrexate—multiple sclerosis	0.0007	0.00953	CcSEcCtD
Salicylic acid—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000697	0.159	CbGdCrCtD
Salicylic acid—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000686	0.156	CbGdCrCtD
Salicylic acid—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000686	0.156	CbGdCrCtD
Salicylic acid—Oesophagitis—Methylprednisolone—multiple sclerosis	0.000672	0.00914	CcSEcCtD
Salicylic acid—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00067	0.153	CbGdCrCtD
Salicylic acid—Ecchymosis—Triamcinolone—multiple sclerosis	0.000666	0.00907	CcSEcCtD
Salicylic acid—Ecchymosis—Methylprednisolone—multiple sclerosis	0.000665	0.00905	CcSEcCtD
Salicylic acid—Pruritus—Fingolimod—multiple sclerosis	0.000662	0.009	CcSEcCtD
Salicylic acid—Erythema—Cladribine—multiple sclerosis	0.000649	0.00884	CcSEcCtD
Salicylic acid—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.000647	0.00881	CcSEcCtD
Salicylic acid—Diarrhoea—Fingolimod—multiple sclerosis	0.00064	0.00871	CcSEcCtD
Salicylic acid—Skin exfoliation—Betamethasone—multiple sclerosis	0.000638	0.00869	CcSEcCtD
Salicylic acid—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000638	0.00869	CcSEcCtD
Salicylic acid—Dizziness—Fingolimod—multiple sclerosis	0.000618	0.00842	CcSEcCtD
Salicylic acid—Oesophagitis—Dexamethasone—multiple sclerosis	0.000611	0.00831	CcSEcCtD
Salicylic acid—Oesophagitis—Betamethasone—multiple sclerosis	0.000611	0.00831	CcSEcCtD
Salicylic acid—Ecchymosis—Betamethasone—multiple sclerosis	0.000604	0.00823	CcSEcCtD
Salicylic acid—Ecchymosis—Dexamethasone—multiple sclerosis	0.000604	0.00823	CcSEcCtD
Salicylic acid—Headache—Fingolimod—multiple sclerosis	0.000586	0.00797	CcSEcCtD
Salicylic acid—Erythema multiforme—Azathioprine—multiple sclerosis	0.000574	0.00781	CcSEcCtD
Salicylic acid—Weight increased—Mitoxantrone—multiple sclerosis	0.000558	0.00759	CcSEcCtD
Salicylic acid—Skin exfoliation—Prednisone—multiple sclerosis	0.000556	0.00757	CcSEcCtD
Salicylic acid—Drowsiness—Mitoxantrone—multiple sclerosis	0.000546	0.00744	CcSEcCtD
Salicylic acid—Confusional state—Cladribine—multiple sclerosis	0.000534	0.00727	CcSEcCtD
Salicylic acid—Oesophagitis—Prednisone—multiple sclerosis	0.000532	0.00724	CcSEcCtD
Salicylic acid—Oedema—Cladribine—multiple sclerosis	0.00053	0.00721	CcSEcCtD
Salicylic acid—Ecchymosis—Prednisone—multiple sclerosis	0.000526	0.00716	CcSEcCtD
Salicylic acid—Anorexia—Cladribine—multiple sclerosis	0.000505	0.00688	CcSEcCtD
Salicylic acid—Lethargy—Betamethasone—multiple sclerosis	0.000495	0.00674	CcSEcCtD
Salicylic acid—Lethargy—Dexamethasone—multiple sclerosis	0.000495	0.00674	CcSEcCtD
Salicylic acid—Hepatitis—Mitoxantrone—multiple sclerosis	0.00049	0.00667	CcSEcCtD
Salicylic acid—Somnolence—Cladribine—multiple sclerosis	0.000471	0.00641	CcSEcCtD
Salicylic acid—Skin exfoliation—Methotrexate—multiple sclerosis	0.000464	0.00632	CcSEcCtD
Salicylic acid—Asthma—Triamcinolone—multiple sclerosis	0.000462	0.00629	CcSEcCtD
Salicylic acid—Decreased appetite—Cladribine—multiple sclerosis	0.000461	0.00627	CcSEcCtD
Salicylic acid—Weight increased—Prednisolone—multiple sclerosis	0.000457	0.00623	CcSEcCtD
Salicylic acid—Pain—Cladribine—multiple sclerosis	0.000453	0.00617	CcSEcCtD
Salicylic acid—Constipation—Cladribine—multiple sclerosis	0.000453	0.00617	CcSEcCtD
Salicylic acid—Ecchymosis—Methotrexate—multiple sclerosis	0.00044	0.00599	CcSEcCtD
Salicylic acid—Feeling abnormal—Cladribine—multiple sclerosis	0.000437	0.00595	CcSEcCtD
Salicylic acid—Lethargy—Prednisone—multiple sclerosis	0.000431	0.00587	CcSEcCtD
Salicylic acid—Erythema—Mitoxantrone—multiple sclerosis	0.000427	0.00581	CcSEcCtD
Salicylic acid—Urticaria—Cladribine—multiple sclerosis	0.000421	0.00573	CcSEcCtD
Salicylic acid—Weight increased—Triamcinolone—multiple sclerosis	0.000421	0.00573	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000421	0.0958	CbGdCrCtD
Salicylic acid—Weight increased—Methylprednisolone—multiple sclerosis	0.00042	0.00571	CcSEcCtD
Salicylic acid—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000418	0.00569	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000414	0.0943	CbGdCrCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000414	0.0943	CbGdCrCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000404	0.0921	CbGdCrCtD
Salicylic acid—Epistaxis—Triamcinolone—multiple sclerosis	0.000389	0.00529	CcSEcCtD
Salicylic acid—Weight increased—Dexamethasone—multiple sclerosis	0.000382	0.0052	CcSEcCtD
Salicylic acid—Weight increased—Betamethasone—multiple sclerosis	0.000382	0.0052	CcSEcCtD
Salicylic acid—Pruritus—Cladribine—multiple sclerosis	0.000375	0.0051	CcSEcCtD
Salicylic acid—Hallucination—Methylprednisolone—multiple sclerosis	0.000367	0.005	CcSEcCtD
Salicylic acid—Diarrhoea—Cladribine—multiple sclerosis	0.000363	0.00494	CcSEcCtD
Salicylic acid—Lethargy—Methotrexate—multiple sclerosis	0.00036	0.00491	CcSEcCtD
Salicylic acid—Feeling abnormal—Azathioprine—multiple sclerosis	0.000355	0.00483	CcSEcCtD
Salicylic acid—Confusional state—Mitoxantrone—multiple sclerosis	0.000351	0.00478	CcSEcCtD
Salicylic acid—Dizziness—Cladribine—multiple sclerosis	0.00035	0.00477	CcSEcCtD
Salicylic acid—Erythema—Prednisolone—multiple sclerosis	0.00035	0.00477	CcSEcCtD
Salicylic acid—Oedema—Mitoxantrone—multiple sclerosis	0.000348	0.00474	CcSEcCtD
Salicylic acid—Vomiting—Cladribine—multiple sclerosis	0.000337	0.00459	CcSEcCtD
Salicylic acid—Rash—Cladribine—multiple sclerosis	0.000334	0.00455	CcSEcCtD
Salicylic acid—Hallucination—Dexamethasone—multiple sclerosis	0.000334	0.00455	CcSEcCtD
Salicylic acid—Hallucination—Betamethasone—multiple sclerosis	0.000334	0.00455	CcSEcCtD
Salicylic acid—Dermatitis—Cladribine—multiple sclerosis	0.000334	0.00454	CcSEcCtD
Salicylic acid—Weight increased—Prednisone—multiple sclerosis	0.000332	0.00452	CcSEcCtD
Salicylic acid—Anorexia—Mitoxantrone—multiple sclerosis	0.000332	0.00452	CcSEcCtD
Salicylic acid—Headache—Cladribine—multiple sclerosis	0.000332	0.00452	CcSEcCtD
Salicylic acid—Erythema—Triamcinolone—multiple sclerosis	0.000322	0.00438	CcSEcCtD
Salicylic acid—Erythema—Methylprednisolone—multiple sclerosis	0.000321	0.00437	CcSEcCtD
Salicylic acid—Dysgeusia—Triamcinolone—multiple sclerosis	0.000315	0.00429	CcSEcCtD
Salicylic acid—Nausea—Cladribine—multiple sclerosis	0.000315	0.00429	CcSEcCtD
Salicylic acid—Somnolence—Mitoxantrone—multiple sclerosis	0.00031	0.00422	CcSEcCtD
Salicylic acid—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000307	0.00417	CcSEcCtD
Salicylic acid—Asthma—Methotrexate—multiple sclerosis	0.000305	0.00415	CcSEcCtD
Salicylic acid—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000303	0.00412	CcSEcCtD
Salicylic acid—Pain—Mitoxantrone—multiple sclerosis	0.000298	0.00406	CcSEcCtD
Salicylic acid—Constipation—Mitoxantrone—multiple sclerosis	0.000298	0.00406	CcSEcCtD
Salicylic acid—Diarrhoea—Azathioprine—multiple sclerosis	0.000295	0.00401	CcSEcCtD
Salicylic acid—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000293	0.00398	CcSEcCtD
Salicylic acid—Erythema—Betamethasone—multiple sclerosis	0.000292	0.00398	CcSEcCtD
Salicylic acid—Erythema—Dexamethasone—multiple sclerosis	0.000292	0.00398	CcSEcCtD
Salicylic acid—Hallucination—Prednisone—multiple sclerosis	0.000291	0.00396	CcSEcCtD
Salicylic acid—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000287	0.00391	CcSEcCtD
Salicylic acid—Oedema—Prednisolone—multiple sclerosis	0.000286	0.00389	CcSEcCtD
Salicylic acid—Dizziness—Azathioprine—multiple sclerosis	0.000285	0.00388	CcSEcCtD
Salicylic acid—Urticaria—Mitoxantrone—multiple sclerosis	0.000277	0.00377	CcSEcCtD
Salicylic acid—Vomiting—Azathioprine—multiple sclerosis	0.000274	0.00373	CcSEcCtD
Salicylic acid—Drowsiness—Methotrexate—multiple sclerosis	0.000272	0.0037	CcSEcCtD
Salicylic acid—Rash—Azathioprine—multiple sclerosis	0.000272	0.0037	CcSEcCtD
Salicylic acid—Dermatitis—Azathioprine—multiple sclerosis	0.000271	0.0037	CcSEcCtD
Salicylic acid—Headache—Azathioprine—multiple sclerosis	0.00027	0.00367	CcSEcCtD
Salicylic acid—Confusional state—Methylprednisolone—multiple sclerosis	0.000264	0.0036	CcSEcCtD
Salicylic acid—Oedema—Triamcinolone—multiple sclerosis	0.000263	0.00358	CcSEcCtD
Salicylic acid—Epistaxis—Methotrexate—multiple sclerosis	0.000257	0.00349	CcSEcCtD
Salicylic acid—Nausea—Azathioprine—multiple sclerosis	0.000256	0.00348	CcSEcCtD
Salicylic acid—Erythema—Prednisone—multiple sclerosis	0.000254	0.00346	CcSEcCtD
Salicylic acid—Pain—Prednisolone—multiple sclerosis	0.000244	0.00333	CcSEcCtD
Salicylic acid—Hepatitis—Methotrexate—multiple sclerosis	0.000244	0.00333	CcSEcCtD
Salicylic acid—Oedema—Dexamethasone—multiple sclerosis	0.000238	0.00325	CcSEcCtD
Salicylic acid—Oedema—Betamethasone—multiple sclerosis	0.000238	0.00325	CcSEcCtD
Salicylic acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000238	0.00324	CcSEcCtD
Salicylic acid—Feeling abnormal—Prednisolone—multiple sclerosis	0.000236	0.00321	CcSEcCtD
Salicylic acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000231	0.00315	CcSEcCtD
Salicylic acid—Erythema multiforme—Methotrexate—multiple sclerosis	0.000231	0.00314	CcSEcCtD
Salicylic acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000231	0.00314	CcSEcCtD
Salicylic acid—Tinnitus—Methotrexate—multiple sclerosis	0.000228	0.0031	CcSEcCtD
Salicylic acid—Anorexia—Dexamethasone—multiple sclerosis	0.000227	0.00309	CcSEcCtD
Salicylic acid—Anorexia—Betamethasone—multiple sclerosis	0.000227	0.00309	CcSEcCtD
Salicylic acid—Urticaria—Prednisolone—multiple sclerosis	0.000227	0.00309	CcSEcCtD
Salicylic acid—Pain—Triamcinolone—multiple sclerosis	0.000225	0.00306	CcSEcCtD
Salicylic acid—Magnesium salicylate—ALB—multiple sclerosis	0.000224	0.388	CrCbGaD
Salicylic acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000222	0.00302	CcSEcCtD
Salicylic acid—Rash—Mitoxantrone—multiple sclerosis	0.00022	0.00299	CcSEcCtD
Salicylic acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000219	0.00299	CcSEcCtD
Salicylic acid—Headache—Mitoxantrone—multiple sclerosis	0.000218	0.00297	CcSEcCtD
Salicylic acid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000217	0.00295	CcSEcCtD
Salicylic acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000216	0.00294	CcSEcCtD
Salicylic acid—Erythema—Methotrexate—multiple sclerosis	0.000213	0.00289	CcSEcCtD
Salicylic acid—Diflunisal—ALB—multiple sclerosis	0.000211	0.365	CrCbGaD
Salicylic acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.00021	0.00286	CcSEcCtD
Salicylic acid—Dyspepsia—Betamethasone—multiple sclerosis	0.00021	0.00286	CcSEcCtD
Salicylic acid—Urticaria—Triamcinolone—multiple sclerosis	0.000209	0.00284	CcSEcCtD
Salicylic acid—Urticaria—Methylprednisolone—multiple sclerosis	0.000208	0.00284	CcSEcCtD
Salicylic acid—Dysgeusia—Methotrexate—multiple sclerosis	0.000208	0.00283	CcSEcCtD
Salicylic acid—Oedema—Prednisone—multiple sclerosis	0.000208	0.00283	CcSEcCtD
Salicylic acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000207	0.00282	CcSEcCtD
Salicylic acid—Decreased appetite—Betamethasone—multiple sclerosis	0.000207	0.00282	CcSEcCtD
Salicylic acid—Nausea—Mitoxantrone—multiple sclerosis	0.000207	0.00282	CcSEcCtD
Salicylic acid—Pain—Betamethasone—multiple sclerosis	0.000204	0.00278	CcSEcCtD
Salicylic acid—Pain—Dexamethasone—multiple sclerosis	0.000204	0.00278	CcSEcCtD
Salicylic acid—Anorexia—Prednisone—multiple sclerosis	0.000198	0.00269	CcSEcCtD
Salicylic acid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000197	0.00268	CcSEcCtD
Salicylic acid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000197	0.00268	CcSEcCtD
Salicylic acid—Urticaria—Dexamethasone—multiple sclerosis	0.000189	0.00258	CcSEcCtD
Salicylic acid—Urticaria—Betamethasone—multiple sclerosis	0.000189	0.00258	CcSEcCtD
Salicylic acid—Dizziness—Prednisolone—multiple sclerosis	0.000189	0.00257	CcSEcCtD
Salicylic acid—Pruritus—Triamcinolone—multiple sclerosis	0.000186	0.00253	CcSEcCtD
Salicylic acid—Pruritus—Methylprednisolone—multiple sclerosis	0.000186	0.00253	CcSEcCtD
Salicylic acid—Dyspepsia—Prednisone—multiple sclerosis	0.000183	0.00249	CcSEcCtD
Salicylic acid—Decreased appetite—Prednisone—multiple sclerosis	0.000181	0.00246	CcSEcCtD
Salicylic acid—Rash—Prednisolone—multiple sclerosis	0.00018	0.00245	CcSEcCtD
Salicylic acid—Dermatitis—Prednisolone—multiple sclerosis	0.00018	0.00245	CcSEcCtD
Salicylic acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000179	0.00244	CcSEcCtD
Salicylic acid—Headache—Prednisolone—multiple sclerosis	0.000179	0.00244	CcSEcCtD
Salicylic acid—Constipation—Prednisone—multiple sclerosis	0.000178	0.00242	CcSEcCtD
Salicylic acid—Confusional state—Methotrexate—multiple sclerosis	0.000175	0.00238	CcSEcCtD
Salicylic acid—Dizziness—Triamcinolone—multiple sclerosis	0.000174	0.00237	CcSEcCtD
Salicylic acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000173	0.00236	CcSEcCtD
Salicylic acid—Feeling abnormal—Prednisone—multiple sclerosis	0.000171	0.00233	CcSEcCtD
Salicylic acid—Nausea—Prednisolone—multiple sclerosis	0.00017	0.00231	CcSEcCtD
Salicylic acid—Pruritus—Betamethasone—multiple sclerosis	0.000169	0.0023	CcSEcCtD
Salicylic acid—Pruritus—Dexamethasone—multiple sclerosis	0.000169	0.0023	CcSEcCtD
Salicylic acid—Vomiting—Triamcinolone—multiple sclerosis	0.000167	0.00227	CcSEcCtD
Salicylic acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000167	0.00227	CcSEcCtD
Salicylic acid—Rash—Triamcinolone—multiple sclerosis	0.000166	0.00226	CcSEcCtD
Salicylic acid—Dermatitis—Triamcinolone—multiple sclerosis	0.000166	0.00225	CcSEcCtD
Salicylic acid—Anorexia—Methotrexate—multiple sclerosis	0.000165	0.00225	CcSEcCtD
Salicylic acid—Rash—Methylprednisolone—multiple sclerosis	0.000165	0.00225	CcSEcCtD
Salicylic acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000165	0.00225	CcSEcCtD
Salicylic acid—Urticaria—Prednisone—multiple sclerosis	0.000165	0.00225	CcSEcCtD
Salicylic acid—Headache—Triamcinolone—multiple sclerosis	0.000165	0.00224	CcSEcCtD
Salicylic acid—Headache—Methylprednisolone—multiple sclerosis	0.000164	0.00224	CcSEcCtD
Salicylic acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.000163	0.00222	CcSEcCtD
Salicylic acid—Diarrhoea—Betamethasone—multiple sclerosis	0.000163	0.00222	CcSEcCtD
Salicylic acid—Dizziness—Betamethasone—multiple sclerosis	0.000158	0.00215	CcSEcCtD
Salicylic acid—Dizziness—Dexamethasone—multiple sclerosis	0.000158	0.00215	CcSEcCtD
Salicylic acid—Nausea—Triamcinolone—multiple sclerosis	0.000156	0.00213	CcSEcCtD
Salicylic acid—Nausea—Methylprednisolone—multiple sclerosis	0.000156	0.00212	CcSEcCtD
Salicylic acid—Somnolence—Methotrexate—multiple sclerosis	0.000154	0.0021	CcSEcCtD
Salicylic acid—Dyspepsia—Methotrexate—multiple sclerosis	0.000153	0.00208	CcSEcCtD
Salicylic acid—Vomiting—Dexamethasone—multiple sclerosis	0.000152	0.00206	CcSEcCtD
Salicylic acid—Vomiting—Betamethasone—multiple sclerosis	0.000152	0.00206	CcSEcCtD
Salicylic acid—Decreased appetite—Methotrexate—multiple sclerosis	0.000151	0.00205	CcSEcCtD
Salicylic acid—Rash—Dexamethasone—multiple sclerosis	0.00015	0.00205	CcSEcCtD
Salicylic acid—Rash—Betamethasone—multiple sclerosis	0.00015	0.00205	CcSEcCtD
Salicylic acid—Dermatitis—Betamethasone—multiple sclerosis	0.00015	0.00204	CcSEcCtD
Salicylic acid—Dermatitis—Dexamethasone—multiple sclerosis	0.00015	0.00204	CcSEcCtD
Salicylic acid—Headache—Dexamethasone—multiple sclerosis	0.000149	0.00203	CcSEcCtD
Salicylic acid—Headache—Betamethasone—multiple sclerosis	0.000149	0.00203	CcSEcCtD
Salicylic acid—Pain—Methotrexate—multiple sclerosis	0.000148	0.00202	CcSEcCtD
Salicylic acid—Pruritus—Prednisone—multiple sclerosis	0.000147	0.002	CcSEcCtD
Salicylic acid—Feeling abnormal—Methotrexate—multiple sclerosis	0.000143	0.00195	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ALB—multiple sclerosis	0.000142	0.247	CrCbGaD
Salicylic acid—Diarrhoea—Prednisone—multiple sclerosis	0.000142	0.00193	CcSEcCtD
Salicylic acid—Nausea—Dexamethasone—multiple sclerosis	0.000142	0.00193	CcSEcCtD
Salicylic acid—Nausea—Betamethasone—multiple sclerosis	0.000142	0.00193	CcSEcCtD
Salicylic acid—Urticaria—Methotrexate—multiple sclerosis	0.000138	0.00188	CcSEcCtD
Salicylic acid—Dizziness—Prednisone—multiple sclerosis	0.000137	0.00187	CcSEcCtD
Salicylic acid—Vomiting—Prednisone—multiple sclerosis	0.000132	0.0018	CcSEcCtD
Salicylic acid—Rash—Prednisone—multiple sclerosis	0.000131	0.00178	CcSEcCtD
Salicylic acid—Dermatitis—Prednisone—multiple sclerosis	0.000131	0.00178	CcSEcCtD
Salicylic acid—Headache—Prednisone—multiple sclerosis	0.00013	0.00177	CcSEcCtD
Salicylic acid—Nausea—Prednisone—multiple sclerosis	0.000123	0.00168	CcSEcCtD
Salicylic acid—Pruritus—Methotrexate—multiple sclerosis	0.000123	0.00167	CcSEcCtD
Salicylic acid—Diarrhoea—Methotrexate—multiple sclerosis	0.000119	0.00162	CcSEcCtD
Salicylic acid—Dizziness—Methotrexate—multiple sclerosis	0.000115	0.00156	CcSEcCtD
Salicylic acid—Vomiting—Methotrexate—multiple sclerosis	0.00011	0.0015	CcSEcCtD
Salicylic acid—Rash—Methotrexate—multiple sclerosis	0.000109	0.00149	CcSEcCtD
Salicylic acid—Dermatitis—Methotrexate—multiple sclerosis	0.000109	0.00149	CcSEcCtD
Salicylic acid—Headache—Methotrexate—multiple sclerosis	0.000109	0.00148	CcSEcCtD
Salicylic acid—Nausea—Methotrexate—multiple sclerosis	0.000103	0.0014	CcSEcCtD
Salicylic acid—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.78e-05	0.00139	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	7.66e-05	0.00137	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	7.62e-05	0.00137	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.61e-05	0.00136	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD28—multiple sclerosis	7.6e-05	0.00136	CbGpPWpGaD
Salicylic acid—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.57e-05	0.00136	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.38e-05	0.00132	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.3e-05	0.00131	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.3e-05	0.00131	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—CCL2—multiple sclerosis	7.29e-05	0.00131	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.26e-05	0.0013	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—FAS—multiple sclerosis	7.17e-05	0.00129	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.16e-05	0.00128	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GPC5—multiple sclerosis	7.13e-05	0.00128	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	7.13e-05	0.00128	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.1e-05	0.00127	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.07e-05	0.00127	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	7.05e-05	0.00126	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.97e-05	0.00125	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.95e-05	0.00125	CbGpPWpGaD
Salicylic acid—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.85e-05	0.00123	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	6.84e-05	0.00123	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	6.79e-05	0.00122	CbGpPWpGaD
Salicylic acid—SLC16A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.72e-05	0.00121	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	6.67e-05	0.0012	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.62e-05	0.00119	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	6.6e-05	0.00118	CbGpPWpGaD
Salicylic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.58e-05	0.00118	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	6.47e-05	0.00116	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.44e-05	0.00116	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.44e-05	0.00115	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	6.32e-05	0.00113	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.3e-05	0.00113	CbGpPWpGaD
Salicylic acid—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.22e-05	0.00111	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IFNG—multiple sclerosis	6.2e-05	0.00111	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	6.19e-05	0.00111	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.16e-05	0.0011	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	6.1e-05	0.00109	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—BCHE—multiple sclerosis	6.09e-05	0.00109	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.08e-05	0.00109	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.04e-05	0.00108	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.95e-05	0.00107	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—RRM1—multiple sclerosis	5.91e-05	0.00106	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.91e-05	0.00106	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.91e-05	0.00106	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.83e-05	0.00105	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SRM—multiple sclerosis	5.82e-05	0.00104	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	5.79e-05	0.00104	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCL3—multiple sclerosis	5.78e-05	0.00104	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	5.66e-05	0.00101	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTGER4—multiple sclerosis	5.56e-05	0.000997	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL1B—multiple sclerosis	5.53e-05	0.000991	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL2—multiple sclerosis	5.51e-05	0.000987	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PGR—multiple sclerosis	5.48e-05	0.000982	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IL2RA—multiple sclerosis	5.46e-05	0.000978	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.43e-05	0.000973	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD86—multiple sclerosis	5.42e-05	0.000972	CbGpPWpGaD
Salicylic acid—PTGS1—Biological oxidations—POMC—multiple sclerosis	5.39e-05	0.000966	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCR3—multiple sclerosis	5.37e-05	0.000963	CbGpPWpGaD
Salicylic acid—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.33e-05	0.000956	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CD28—multiple sclerosis	5.32e-05	0.000954	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.3e-05	0.000949	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PLEK—multiple sclerosis	5.29e-05	0.000949	CbGpPWpGaD
Salicylic acid—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.23e-05	0.000937	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCR2—multiple sclerosis	5.22e-05	0.000937	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.15e-05	0.000923	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.99e-05	0.000895	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	4.96e-05	0.000889	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	4.93e-05	0.000884	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.92e-05	0.000883	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.84e-05	0.000867	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.84e-05	0.000867	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CNR1—multiple sclerosis	4.82e-05	0.000864	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	4.81e-05	0.000863	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CCR5—multiple sclerosis	4.81e-05	0.000862	CbGpPWpGaD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.79e-05	0.000858	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.7e-05	0.000843	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HLA-A—multiple sclerosis	4.69e-05	0.00084	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SRM—multiple sclerosis	4.62e-05	0.000828	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.58e-05	0.000821	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.39e-05	0.000787	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	4.39e-05	0.000787	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—APOE—multiple sclerosis	4.37e-05	0.000784	CbGpPWpGaD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.36e-05	0.000782	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL10—multiple sclerosis	4.34e-05	0.000778	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	4.29e-05	0.00077	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	4.28e-05	0.000767	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.19e-05	0.000752	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.18e-05	0.000749	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.13e-05	0.000741	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP27B1—multiple sclerosis	4.1e-05	0.000735	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP24A1—multiple sclerosis	4.1e-05	0.000735	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	4.05e-05	0.000726	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.01e-05	0.00072	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—multiple sclerosis	4.01e-05	0.000719	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4e-05	0.000718	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	4e-05	0.000718	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.98e-05	0.000713	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD80—multiple sclerosis	3.95e-05	0.000709	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ALB—multiple sclerosis	3.95e-05	0.000707	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	3.94e-05	0.000706	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.84e-05	0.000689	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CD86—multiple sclerosis	3.8e-05	0.000681	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPC5—multiple sclerosis	3.75e-05	0.000672	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCL5—multiple sclerosis	3.74e-05	0.00067	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SRM—multiple sclerosis	3.74e-05	0.00067	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SELE—multiple sclerosis	3.73e-05	0.000668	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—TGFB1—multiple sclerosis	3.68e-05	0.00066	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—APOE—multiple sclerosis	3.66e-05	0.000657	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.62e-05	0.000649	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	3.57e-05	0.00064	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GPC5—multiple sclerosis	3.55e-05	0.000637	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.54e-05	0.000634	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	3.51e-05	0.000629	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.48e-05	0.000624	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SPP1—multiple sclerosis	3.46e-05	0.000621	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.42e-05	0.000612	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—BCHE—multiple sclerosis	3.4e-05	0.000609	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCR5—multiple sclerosis	3.37e-05	0.000604	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	3.34e-05	0.000599	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TYK2—multiple sclerosis	3.34e-05	0.000599	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	3.34e-05	0.000598	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2RA—multiple sclerosis	3.32e-05	0.000595	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SRM—multiple sclerosis	3.27e-05	0.000587	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	3.27e-05	0.000586	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.26e-05	0.000584	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP24A1—multiple sclerosis	3.25e-05	0.000583	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP27B1—multiple sclerosis	3.25e-05	0.000583	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL6—multiple sclerosis	3.24e-05	0.00058	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.2e-05	0.000574	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IL2—multiple sclerosis	3.2e-05	0.000574	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.19e-05	0.000571	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.18e-05	0.00057	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	3.18e-05	0.00057	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.17e-05	0.000569	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.16e-05	0.000567	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—POMC—multiple sclerosis	3.15e-05	0.000564	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	3.11e-05	0.000558	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—RRM1—multiple sclerosis	3.11e-05	0.000557	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—APOE—multiple sclerosis	3.06e-05	0.000549	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SRM—multiple sclerosis	3.06e-05	0.000548	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.04e-05	0.000546	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD4—multiple sclerosis	3.02e-05	0.000541	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPC5—multiple sclerosis	2.98e-05	0.000533	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—ALB—multiple sclerosis	2.87e-05	0.000514	CbGpPWpGaD
Salicylic acid—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.83e-05	0.000508	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.8e-05	0.000503	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CD80—multiple sclerosis	2.77e-05	0.000497	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ITGA4—multiple sclerosis	2.7e-05	0.000483	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IFNB1—multiple sclerosis	2.68e-05	0.00048	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.66e-05	0.000476	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP24A1—multiple sclerosis	2.63e-05	0.000472	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP27B1—multiple sclerosis	2.63e-05	0.000472	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—POMC—multiple sclerosis	2.63e-05	0.000472	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCL2—multiple sclerosis	2.57e-05	0.000462	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.57e-05	0.000461	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.57e-05	0.000461	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	2.51e-05	0.000451	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	2.5e-05	0.000447	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—RRM1—multiple sclerosis	2.47e-05	0.000442	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	2.45e-05	0.000439	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.41e-05	0.000432	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPC5—multiple sclerosis	2.41e-05	0.000432	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TYK2—multiple sclerosis	2.34e-05	0.000419	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—STAT3—multiple sclerosis	2.34e-05	0.000419	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RPL5—multiple sclerosis	2.31e-05	0.000414	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.31e-05	0.000413	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.31e-05	0.000413	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.27e-05	0.000408	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.27e-05	0.000407	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.23e-05	0.000399	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.22e-05	0.000397	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SLC11A1—multiple sclerosis	2.21e-05	0.000397	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—multiple sclerosis	2.17e-05	0.000389	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TGFB1—multiple sclerosis	2.17e-05	0.000388	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000386	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000386	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MAPK1—multiple sclerosis	2.13e-05	0.000381	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.12e-05	0.00038	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPC5—multiple sclerosis	2.11e-05	0.000378	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.11e-05	0.000377	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.09e-05	0.000375	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.07e-05	0.000371	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—APOE—multiple sclerosis	2.04e-05	0.000366	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000358	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.97e-05	0.000353	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—multiple sclerosis	1.95e-05	0.000349	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.91e-05	0.000343	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.89e-05	0.000338	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2RA—multiple sclerosis	1.84e-05	0.00033	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—multiple sclerosis	1.84e-05	0.00033	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—BCHE—multiple sclerosis	1.78e-05	0.00032	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD28—multiple sclerosis	1.77e-05	0.000317	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—POMC—multiple sclerosis	1.75e-05	0.000315	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—RRM1—multiple sclerosis	1.75e-05	0.000313	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.64e-05	0.000295	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—multiple sclerosis	1.64e-05	0.000293	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.63e-05	0.000293	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—multiple sclerosis	1.63e-05	0.000293	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000293	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.61e-05	0.000289	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.61e-05	0.000288	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.6e-05	0.000287	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ALB—multiple sclerosis	1.6e-05	0.000287	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.58e-05	0.000283	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.55e-05	0.000277	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—multiple sclerosis	1.52e-05	0.000273	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TGFB1—multiple sclerosis	1.52e-05	0.000272	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.5e-05	0.000269	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.5e-05	0.000269	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK1—multiple sclerosis	1.49e-05	0.000267	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000254	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	0.000238	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.27e-05	0.000227	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD86—multiple sclerosis	1.26e-05	0.000226	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BCHE—multiple sclerosis	1.15e-05	0.000205	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—multiple sclerosis	1.14e-05	0.000205	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CCR5—multiple sclerosis	1.12e-05	0.0002	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HLA-A—multiple sclerosis	1.09e-05	0.000195	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.09e-05	0.000195	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—multiple sclerosis	1.08e-05	0.000194	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000192	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOE—multiple sclerosis	1.02e-05	0.000182	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.01e-05	0.000181	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BCHE—multiple sclerosis	1e-05	0.00018	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.92e-06	0.000178	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.38e-06	0.000168	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—POMC—multiple sclerosis	9.22e-06	0.000165	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD80—multiple sclerosis	9.2e-06	0.000165	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOE—multiple sclerosis	8.52e-06	0.000153	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TGFB1—multiple sclerosis	8.42e-06	0.000151	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—multiple sclerosis	8.4e-06	0.000151	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK1—multiple sclerosis	8.26e-06	0.000148	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TYK2—multiple sclerosis	7.76e-06	0.000139	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—POMC—multiple sclerosis	7.32e-06	0.000131	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—multiple sclerosis	7.02e-06	0.000126	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOE—multiple sclerosis	6.89e-06	0.000124	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—multiple sclerosis	6.67e-06	0.00012	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOE—multiple sclerosis	6.04e-06	0.000108	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—POMC—multiple sclerosis	5.92e-06	0.000106	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOE—multiple sclerosis	5.64e-06	0.000101	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—multiple sclerosis	5.44e-06	9.74e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—POMC—multiple sclerosis	5.19e-06	9.3e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—multiple sclerosis	5.05e-06	9.06e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFB1—multiple sclerosis	5.04e-06	9.03e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK1—multiple sclerosis	4.94e-06	8.86e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—POMC—multiple sclerosis	4.85e-06	8.69e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—multiple sclerosis	4.73e-06	8.48e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—multiple sclerosis	4.42e-06	7.92e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—multiple sclerosis	3.8e-06	6.81e-05	CbGpPWpGaD
